ProCE Banner Activity

New Developments in HR-Positive/HER2-Negative Breast Cancer: Insights From SABCS 2019

Clinical Thought
Get insights from Joyce O’Shaughnessy, MD, on key studies in HR-positive/HER2-negative breast cancer presented at the 2019 Breast Cancer meeting in San Antonio.

Released: January 31, 2020

Expiration: January 29, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Puma Biotechnology, Inc.

Seagen